康妇炎胶囊联合丹红注射液治疗慢性盆腔炎的临床观察.docVIP

康妇炎胶囊联合丹红注射液治疗慢性盆腔炎的临床观察 　　[摘要] 目的 探讨康妇炎胶囊联合丹红注射液治疗慢性盆腔炎的效果。 方法 回顾性分析病例资料，选择2010年1月～2011年7月在我院门诊接受治疗的慢性盆腔炎患者88例为研究对象，随机分为观察组和治疗组。观察两组有效率及不良反应。 结果 观察组总有效例数41例，有效率达95.65%，对照组有效例数29例，总有效率69.05%。两组比较差异有统计学意义（P0.05）。 结论 康妇炎胶囊联合丹红注射液治疗慢性盆腔炎有显著疗效，该方法安全、实用、易于推广。 　　[关键词] 慢性盆腔炎；康妇炎胶囊；丹红注射液 　　[中图分类号] R711.33 [文献标识码] B [文章编号] 2095-0616（2013）14-72-03 　　Clinical observation of Kangfuyan capsule combined with Danhong injection in the treatment of chronic pelvic inflammatory disease 　　WANG Huifeng JIN Jun LI Ali ZHANG Zhengang 　　Qingyang Hospital of Traditional Chinese Medicine， Qingyang 745000， China 　　[Abstract] Objective To investigate the effect of Kangfuyan capsule combined with Danhong injection in the treatment of chronic pelvic inflammatory disease. Methods The clinical data were retrospectively analyzed. 88 patients with chronic pelvic inflammatory disease selected in out-patients of our hospital from January 2010 to July 2011 were randomly divided into the observation group and the treatment group. The effective rate and adverse reactions of two groups were observed. Results The total effective number of the observation group was 41 cases， the total effective rate was 95.65%； while the total effective number of the control group was 29 cases， the total effective rate was 69.05%. The difference was significant between two groups （P0.05）. Conclusion Kangfuyan capsule combined with Danhong injection in the treatment of chronic pelvic inflammatory disease have a significant effect， and it is safe， practical， easy to popularize. 　　[Key words] Chronic pelvic inflammatory disease； Kangfuyan capsule； Danhong injection 　　慢性盆腔炎常为急性盆腔炎未彻底治疗或患者体质较差病程迁延所致，其发生率在25%左右，但亦可无急性盆腔炎病史。部分慢性盆腔炎仅为急性盆腔炎遗留的病理改变，组织破坏、广泛粘连、增生及瘢痕形成，并无病原体[1]。慢性盆腔炎常造成不孕、异位妊娠、慢性盆腔痛以及盆腔炎性疾病的反复发作，目前慢性盆腔炎尚无特殊有效的治疗方案，给临床治疗造成了很大的困难。按中医理论以清热利湿、活血化瘀、温经散寒，行气活血为治则治疗慢性盆腔炎，疗效确切、满意。 　　1 资料与方法 　　1.1 一般资料 　　选自2010年6月～2011年7月在我院门诊就诊，自愿接受治疗的慢性盆腔炎患者88例，均经医院伦理委员会通过及患儿家属知情同意。随机分为两组，观察组（康妇炎胶囊联合丹红注射液）46例，年龄19～55岁，平均年龄37岁，未婚1例，急